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Specific Immunologic Tolerance to Dinitrofluorobenzene Following 
Topical Application of Dinitrothiocyanobenzene: Modulation by 
Suppressor T Cells 
MASAFUMIIIJIMA, M.D . AND S TEPHEN I. K ATZ, M .D ., PH.D . 
Dermatology Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, U. S . A. 
In order to determine the mecha nism(s) involved in 
the induction of immunologic tolera nce for contact sen-
sitivity via the topical application of a chemical tha t 
sensitizes if given with adjuvant, we utilized the hapten 
dinitrothiocya nobenzene (DNTB). Specific immunologic 
tolerance to dinitrofluorobenzene (DNFB) was induced 
in mice by the topical application of DNTB 7 days before 
sensitization to DNFB. The tolerance could be a brogated 
if cyclophosphamide (200 mg/kg) was given 3 days be-
fore attempted sensitization. Using passive transfer 
studies we found that DNTB induced hapten-specific 
L y t 1 +2- suppressor T cells. These suppressor cells pre -
vented the induction of contact sensitivity but did not 
affect its expression. Lymphocyte proliferation studies, 
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Abbreviations: 
BSS: balanced salt solution 
CY: cyclophosphamide 
DNFB: dinit rot1uorobenzene 
DNP: dinit rophenyl 
DNTB: din itrothiocyanobenzene 
EC: epidermal cell (s) 
Epi: epicutaneous (application) 
FCA: Freund's complete adjuvant 
LNC: lymph node cells 
TNCB: t rini t rochlorobenzene (picryl chloride) 
using ha p tenated epiderma l cells as a n t igen , ind icate 
that lymph node cells obtained 5 days a f ter D NFB sen-
sitization a r e far less responsive if t he mice have re-
ceived DNTB epicutaneously 7 days before the DNFB. 
Binding studies demonstrated tha t DNTB bound t o epi-
derma l cells at least as well as did DNFB. It is pos tula ted 
tha t DNTB induction of suppressor cells is related to th e 
physicochemical intera ction between the hapte n and a n-
tige n-presenting cells in skin. 
Most studies of the mechanisms involved in immunologic 
unresponsiveness (toleran ce) in contact sensit ivity have used 
feeding or i.v. administration of various haptens in order to 
induce tolerance [1,2]. However, several studies have described 
the induction of tolerance in contact sensit ivity following the 
epicutaneous (Epi) application of eit her the hapten itself or of 
a cross-reacting chemical. When t he hapten is applied, eit her 
sub- or supraoptimal concent rations are used on normal skin 
[3- 6] or it is applied directly onto skin t hat has been irradiated 
with small amounts of UV [7], or to abdominal skin of mice 
which have received large amounts of UV irradiation to their 
dorsal skin [8]. Using these methods, the animals are unable 
to become sensit ized to t he haptens even when t he usual 
sensit izing dose is subsequent ly applied. 
Ot her methods used for the induction of tolerance for contact 
sensitivity include t he injection of t he hapten s.c. wit hout 
adjuvant (9], t he injection of a cross-reacting nonsensit izing 
chemical, or the applicat ion of a chemical which sensit izes for 
contact sensit ivity when it is emulsified with Freund's complete 
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adj uvant (FCA) but cannot sen s itize when applied Epi. In this 
regard, Friedlaender and Baer [10] a nd Sommer et a! [11] 
reported that when dinitrothiocyanobenzen e (DNTB) is ap-
plied to guinea pig skin , it induces a state of tolera n ce to DNTB 
or to t he cross- reacting dinitrofluorobenzene (DNFB), a potent 
contact sensitizer. The present study was performed in order 
to determine t h e mechanisms involved in t his unrespon s ive-
ness. We found that, in mice, DNTB application induces hap-
ten-specific Lyt 1 +2- suppressor T cells which act at the induc-
tion phase of contact sensitivity. 
MATERIALS AND METHODS 
Mice 
BALB/c AnN female mice were obtained from the Goodwin Institute 
for Cancer Resea rch Inc. (Plantation, Florida) t hrough t he Animal 
Genetics and Production Branch, DCT, NCI. Groups of 5-6 mice 8-12 
weeks of age were used. 
Antigens 
2,4-D init rofluorobenzene (DNFB, Eastman Kodak Co., Rochester, 
New York), 2,4-di ni trothiocyanobenzene (DNTB, ICN Pharmaceuti -
cals, Inc. , P lainview, New York), and 2,4,6-tr initrochlorobenzene 
(TNCB, Tokyo Kasei, Tokyo, J apan) were used. 
Sensitization and Elicitation for Contact Sensitivity 
DNFB: Twenty microliters of 0.5% DNFB in 4:1 acetone:olive oil 
was painted on t he shaved abdome n on consecutive days (days 0 and 
1). Five days late r (day 5), 20 ,.,I of 0.2% DNFB in the same vehicle 
was applied to t he dorsum of t he ear and the increme nt in ear thickness, 
quantitated with an engineering micrometer, was evaluated 24 h late r 
[6]. An imals t hat were challenged but not sensitized were used as 
negative controls. 
DNTB in Freund's complete adjuvant (DNTB/FCA): Fifteen milli-
grams of DNTB was dissolved in 0.5 ml acetone and added to 7.5 ml 
of FCA (Difco Laboratories, Detroit, Michigan) and 7 ml of saline. 
They were emulsified as described by Sommer et a l [11] . Two-tenths 
of a milligram of this emu lsion (containing 0.2 mg of DNTB) was 
injected into t he ingu inal areas s.c. Seven days later 20 ,.,I of 0.2% 
DNFB was applied to t he ear and ear swelling was assessed 24 h late r. 
TNCB: One hundred microliters of 7% TNCB in 4:1 acetone:olive 
oil was painted on the shaved abdomen and 6 days later 20 ,.,1 of 1% 
TNCB in ol ive oil was applied to both sides of the ear. The increment 
of ear thick ness was assessed 24 h later. 
Induction of tolerance : One hundred microli ters of 2% DNTB in 
acetone was applied to the hair-plucked back of mice 7 days before 
attempted sensitization [11]. These mice were then sensitized according 
to t he sensitization schedules above and the degree of contact sensit iv-
ity assessed. 
The effect of cyclophosphamide (CY) on tolerance induced by DNTB 
application: CY (Cytoxan, Mead Johnson Laboratories, Evansville , 
Indiana) was injected i.p. in a dose of 200 mg/kg either 3 days before 
appl ication of t he to lerogen, DNTB, or 3 days before application of the 
ensitizer, DNFB. 
Transfer of tolerance: Lymph nodes were taken 7 days after appli -
cation of DNTB or 6 days after application of TNCB and cell suspen-
sions prepa red. Nonsensit ized syngeneic mice were injected i.v. with 
these cells; 1 h later sensitization with DNFB was attempted and 5 
days later the mice were challenged. In other experiments t he lymph 
node cells (LNC) were injected i.v. 1 h before attempted cha llenge of 
previously sensit ized recipients. 
Serum transfer: One week after application of DNTB mice were 
exsanguinated. Serum (1 ml) was injected i.v. into naive recipients 
wh ich were then sensitized with DNFB. 
Identification of suppressor cells: LNC were treated with either anti-
theta (thy 1.2) alloantisera (Litton Bionetics) , or with anti -Lyt 1.2 or 
anti-Lyt 2.2 monoclonal antibodies (New England Nuclear) and sub-
sequently treated with complement (from 3-week-old rabbits). LNC 
treated with complement alone were used as cont rols. 
Assessment of tolerance and reversal of tolerance 
% Suppression (unresponsiveness) 
( 
expe rimental - negative control) 
= 1- X100 
positive cont rol - negative 
% Reversal of to lerance 
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(Experimenta l - to lerant control) 
(Positive cont rol - tolerant control) x 100 
Statistical analysis: Each experiment was performed at least 3 t imes. 
Results are expressed as increment in ear t hickness ± SEM. Student's 
t-test was used to assess differences in reactivity. A p value of less t han 
0.01 was considered significant. Representative resul ts are presented. 
Antigen-Specific Prolifera.tion Assay 
Cell preparation: LNC were obtained from nonsensitized mice, from 
mice sensit ized to DNFB 5 and 4 days earlier, from mice which had 
DNTB applied 7 days earlier, or, from mice which received DNTB 12 
days earlier and had DNFB applied 5 and 4 days earlier. Epidermal 
cell (EC) suspensions were prepared (from ear skin) by trypsinization 
[1 2]. 
EC conjugation with DNFB (DNFB-EC): EC were washed 3 t imes 
with Hanks' balanced salt solution (BSS) and incubated for 10 min 
with 0.05 mM DNFB at 37"C. The cells were then washed 3 t imes with 
Hanks' BSS containing 10% fetal calf serum . 
Proliferation assay: Cells were cultured in RPMI 1640 containing 
10% horse serum, 2 mM L-glutamine, 100 U/ml penicillin, 100 l'g/ml 
streptomycin , 0.25 l'g/ ml fun gizone, 5 X 10-5 M 2-mercaptoethanol, 10 
mM HEPES buffer, 1 mM sodium pyruvate, and 0.1 mM nonessentia l 
amino acid for 4 days in a humidified atmosphere of 92% air and 8% 
C02 at 37"C using 96-well flat-bottom microtest plates. As responder 
cells 2 x 105 LNC/well were used, and irradiated (2000 R) DNFB-EC, 
EC, DNFB-conjugated spleen cells or spleen cells alone were used in 
various concentrations (from 0.5 x 105/ well to 2.0 x 105/ well) as 
stimulator cells. One microcurie of [3H]dThd was added to each well 
in the final 20 h of culture. Cells were harvested with a MASH ha rvester 
and radioactivity was assessed by liquid scin t illation counting. 
E numeration of Dinitrophenyl (DNP) Groups per Epidermal Cell 
The number of DNP groups per epidermal cell was determined using 
a modification of the method used by Hale for TNP [13]. Epidermal 
cell suspensions were prepared [12] and the cells were washed and t hen 
incubated with either DNFB (0.5 mM) or DNTB (.02 mM ) fo r 30 min 
at room temperature. The haptenated cells were t hen extensively 
washed with Hanks' BSS conta in ing fetal calf serum and 108 viable 
cells were incubated in 1 ml phosphate-buffered saline with 0.5% 
Nonidet P -40 for 10 min at room temperature. Nuclei and debris were 
separated by centrifugation (100,000 g) for 10 min. The supernatants 
were removed and clarified by the addition of sodium deoxycholate 
(final concent ration 1 %) and absorbancy at 350 nm was determined. 
Cells that had not been dinitrophenylated were used as a blank to 
correct for absorbancy. 
RESULTS 
Induction of Contact Sensitivity with DNFB or DNTB 
DNFB (0.5 %) applied on consecutive days regu larly induced 
strong con tact sen s itivity . On t he other ha nd, DNTB induced 
contact sen s itivity only when emulsified with FCA and given 
s .c. When DNFB or DNTB were applied or when DNTB was 
given with FCA, mice challenged wit h 20 p.l of 1 % DNT~ in 
acetone did not show any s ignificant increment in ear thickness. 
Contact sen s it ivi ty could be elicited only with DNFB. Thus, 
cross-reactivity between DNFB and DNTB in contact sen s itiv-
ity was recognized only when mice were sensitized with DNTB 
in FCA and challenged .with DNFB (Fig 1) . 
Tolerance Induced by Epicutaneously Applied DNTB 
To induce immunologic tolerance, 2% DNTB was applied to 
t h e hai r -plucked back 7 days before t he usua l sensitizing dose 
of DNFB (0.5 % on 2 consecutive days) was used. DNFB-
se ns itized mice which had prior DNTB treatment were s ignif-
icantly less sensitive (65-80 % unrespons ive) than those which 
had n ot h ad prior DNTB (Fig 2). Two applications of 2% 
DNTB, 14 and 7 days before attempted sensitization did not 
alter the level of unresp ons iveness. As well, mice receiving 
DNTB in FCA were less sen s itive to DNFB (52 % unresponsive) 
if they received DNTB Epi before sen s itization . 
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Hapten Specificity of DNTB-Induced Tolerance 
To determine whether the tolerance induced by DNTB ap-
plication was hapten -specific we sensitized mice to t he non -
crossreacting (to DNFB) hapten TNCB. DNFB-sensitized mice 
which had prior DNTB treatment were sign ificant ly less sen-
sitive (71 % unresponsive) t han those which had not received 
prior DNTB treatment. This is in sharp contrast to the lack of 
effect of DNTB app lication on t he subsequent ability to sen -
sitize to TNCB (Fig 3). 
Time Course for Induction of Tolerance by Epicuta.neou.s 
Application of DNTB 
To determine t he optimal t ime for the induction of tolerance 
w it h DNTB, 2% DNTB was applied Epi 14, 10, 7, and 4 days 
before DNFB sensitization. DNTB applied 14 days before 
DNFB sensitization did not affect contact sensitivity. Although 
DNTB applied 10 and 4 days before DNFB sensit ization in-
duced significant tolerance, DNTB applied 7 days before DNFB 
sensit ization induced optimal tolerance (68% unresponsive-
ness) (Fig 4). 
Sensitization 0 
r-~r---~~r-~~~~~~~~~ 
Challenge 
only 
DNFB 
DNTB/ FCA 
DNTB 
FIG 1. Increases in ear t hickness 24 h after t he application of 0.2% 
DNFB to mice to which (1) 0.5% DNFB had been applied 4 and 5 days 
earlier, (2) DNTB emulsified with FCA was injected into t he inguina l 
areas 7 days ea rlier or (3) 2% DNTB was applied 7 days earlier. 
Prior 
treatment Sensitizatio n 
F IG 3. Mice received t he usual sensi- DNFB 
tizing dose of DNFB or TNCB. Certa in 
groups received DNTB epicutaneously 
(DNTB-Epi) 7 days earlier. Ear chal · DNTB-Epi DNFB 
lenge was performed with the appropri-
ate hapten 5 days (i n the case of DNFB) 
or 6 days (TNCB) later. DNTB-Epi TNCB 
TNCB 
E ffect of CY on Tolerance Induced by DNTB 
Two protocols were used in order to determine whether 
treatment with CY affected the tolerance induced by DNTB. 
In the first we gave CY i.p. 3 days before application of DNTB. 
Using this protocol we fou nd t hat CY prevented t he tolerance 
induced by DNTB by only 23 ± 8%. In the second protocol we 
gave CY i.p. 3 days before sensit ization with DNFB (4 days 
after DNTB application) and found t hat CY significantly pre-
vented t he tolerance induced by DNTB (67 ± 1.5% reversal of 
tolerance). A representative experiment is depicted in Fig 5. 
These findings suggested that the unresponsiveness induced by 
DNTB might be due to its induction of suppressor cells. 
Transfer of tolerance with LNC 
To determine whether the tolerance induced by DNTB was 
transferrable with cells, LNC were obtained from mice which 
had received Epi DNTB 7 days earlier. LNC from mice sensi-
tized with Epi TNCB (6 days earlier) were used as controls. 
LNC were injected i.v. into nonsensit ized mice which then 
received the usua l sensit izing dose of DNFB. The recipients 
were challenged on the ear 5 days later with DNFB. In other 
experiments, groups of recipient mice were sensitized with 
DNFB 5 and 4 days before receiving t he LNC i.v. T hey were 
cha llenged on the ear 1 h later. 
LNC from mice which had received Epi DNTB, injected into 
nonsensitized mice, prevented t he recipients from becoming 
Prior 
treatment 
DNTB-Epi 
Ear Increment x 10-2mm 
Sensitization 0 2 4 r-~-T--r-~~~~~ 
Challenge 
only 
DN FB 
DNFB 
FIG 2. Increases in ear t hickness 24 h after application of 0.2% 
DNFB mice which were (1) sensitized wi t h DNFB 4 and 5 days earlier 
or (2) sensitized wi th DNFB 4 and 5 days earlier and had DNTB 
applied 12 days earlier (DNTB-Epi). 
Ear Increment x 10-2mm 
Skin test 0 2 8 10 
DNFB 
DNFB 
DNFB 
TNCB 
TNCB 
TNCB 
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DAYS Ear Increment x 10-2 mm 
-14 -10 -7 -4 2 4 8 10 12 14 16 18 20 
Challenge 
only ~ 
DNFB 
DNTB-Epi DNFB ]-l 
DNTB-Epi DNFB lJ-1 
DNTB-Epi DNFB ~ 
DNTB-Epi DNFB :3" 
FIG 4. DNTB (2%) was applied epicutaneously at varying interva ls 
before attempted sensitization with DNFB. Increases in ear thickness 
were assessed 24 h after challenge. 
DAYS Ear Increment x 10-2mm 
-10 -7 -3 0 2 4 8 10 12 14 16 18 20 
Challenge 
only ~ 
DNFB :81 
DNTB-Epi DNFB ~ 
DNTB-Epi CY · ip DNFB 8----1 
CY-ip DNTB-Epi DNFB 
_B-1 
FIG 5. CY (200 mg/kg) was injected i.p. at varying intervals before 
or after application of DNTB. Sensitization was attempted and in-
creases in ear thickness were assessed 24 h after challenge. 
sensitive (Fig 6). This passive transfer of tolerance was dose 
(of LNC)-dependent and 4 X 107 viable LNC was optimal; this 
number was therefore used for all subsequent LNC transfers. 
LNC (4 X 107) obtained from mice sensitized with TNCB did 
not affect sensit ization with DNFB, nor did heat-killed nonvi-
able LNC from mice which had received Epi DNTB (Fig 6). 
LNC injected into previously sensitized mice did not affect skin 
test reactivity (data not shown). Serum from mice which had 
received DNTB did not affect sensitization to DNFB (data not 
shown). 
The Effect of LNC Treated with anti-theta, anti-Lyt 1.2 or 
anti-Lyt 2.2 and Complement on Tolerance Induced by Epi 
DNTB 
In order to determine whether the cells which transferred 
tolerance were T cells, the LNC were treated with anti-theta 
alloantisera and complement and 4 X 107 viable LNC were 
injected i.v. into nonsensitized mice. Cells treated with comple-
ment alone were used as controls. Using anti-theta (and com-
plement)-treated LNC, DNFB sensitization was not affected, 
which is in sharp contrast to the effect of complement (alone)-
treated cells which significantly suppressed DNFB sensitiza-
tion (Fig 7). Anti-Lyt 2.2 and complement treatment of the 
transferred LNC did not affect their ability to suppress DNFB 
sensitization; however anti-Lyt 1.2 and complement treatment 
of transferred LN C abrogated the ability of the cells to suppress 
DNFB sensitization (Fig 8). Using either of these anti-Lyt 
monoclonal antibodies with complement in lymphocyte prolif-
eration assays (antigen and mitogen), proliferative responses 
were markedly decreased; anti-Lyt 2.2 and complement treat-
ment of responder cells also abrogated the ability of hapten a ted 
cells to generate a cytotoxic T-cell response (data not shown). 
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Lymphocyte Proliferation Assay 
LNC from mice sensitized to DNFB Epi proliferated in a 
dose-dependent manner to DNFB-EC. Normal LNC did not 
respond to DNFB-EC. LNC from mice which received DNTB 
Epi before attempted DNFB sensitization showed a markedly 
diminished response to DNFB-EC. LNC from mice which had 
received Epi DNTB showed a significant proliferation response 
LNC injected 
4x107 Viable 
4X107 Non-Viable 
Challenge 
only 
DNFB 
sensitization 
DNFB 
sensitization 
DNFB 
sensitization 
Ear Increment x 10·2 mm 
0 2 4 6 8 10 12 
FIG 6. LNC from mice which had receive<:! epicutaneous DNTB 7 
days earlier were injected into naive recipients in which DNFB sensi-
tization was attempted 1 h after injection. Five days later, ears were 
challenged and 24 h thereafter ear thickness assessed. 
LNC 
treatment 
no cells 
complement 
alone 
a Thy 1·2+ 
complement 
Sensitization 0 2 
Challenge p only 
DNFB 
DNFB 
DNFB 
Ear Increment x 10-2 mm 
4 6 8 10 12 14 16 18 
l=j--4 
~ 
FIG 7. LNC were treated with complement alone or with anti-Thy 
1.2 antiserum and complement a nd were then injected into naive 
recipients in which DNFB sensitization was attempted. Five days later 
ears were cha llenged and 24 h thereafter ear thickness · assessed. 
LNC 
treatment 
no cells 
complement 
alone 
ex Lyt 1·2 + 
complement 
ex Lyt 2·2 + 
complement 
Ear Increment x 10·2 mm 
Sensitization 0 2 4 6 8 10 12 14 16 
Challenge 
only 
DNFB 
DNFB 
DNFB 
DNFB 
FIG 8. LNC were treated with complement a lone or with anti-Lyt 
1.2 or anti-Lyt 2.2 monoclonal antibodies and complement and were 
then injected into naive recipients in which DNFB sensitization was 
attempted. Five days late r, ears were challenged and 24 h t hereafter 
ear thickness assessed. 
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25 
20 STIMULATOR CELLS 
0 NONE 
m EC105/well 
fi DNFB-EC 105/well 
NORMAL DNFB DNTB/DNFB DNTB 
RESPONDER CELLS 
FIG 9. LNC from (1) normal mice, (2) mice sensitized to epicuta-
neous DNFB, (3) mice to which DNTB was applied 12 days earlier and 
DNFB applied 5 days earlier, or (4) mice which received DNTB alone 
were used as responder cells and epidermal (EC) or DNFB-conjugated 
EC (DNFB-EC) were used as stimulators in a 4-day culture. [3H]dThd 
was added in the final 20 h of culture. Cells were harvested with a 
MASH harvester, and radioactivity was assessed by liquid scintillation 
counting. 
to DNFB-EC when compared to stimulation with EC alone but 
showed a markedly diminished response compared to LNC 
from mice sensitized to DNFB but not pretreated with DNTB 
(Fig 9). Maximal responses were seen on days 4 and 5 of culture. 
Enumeration of DNP Groups per Epidermal Cell 
In order to determine whether epidermal cells were conju-
gated as well with Epi DNTB and DNFB, we made single EC 
suspensions and conjugated them in vitro. The number of DNP 
groups per EC was 2 x 107 when DNTB was used whereas it 
was 107 when DNFB was used. 
DISCUSSION 
Specific immunologic tolerance in contact sensitivity can be 
induced in a variety of ways. Generally, if a chemical is a 
sensitizer when given by one route , i.e., Epi or s.c., and is given 
by a different route i.e., i.v., i.p., or by feeding, it no longer 
sensitizes but induces tolerance (reviewed in [1 ,14]) . As well, a 
chemical that is related to a sensitizer but modified in one of 
several ways can often induce tolerance to the sensitizing 
chemical. Thus tolerance to poison ivy can be induced in 
animals given any one of a series of derivatives substituted in 
the 6 position of the pentadecylcatechol structures (15]. Also 
dinitrobenzenesulfonate [16] and dichloronitrobenzene [17] in-
duce tolerance to DNFB or dinitrochlorobenzene. Another sub-
stance which regularly induces tolerance to DNFB is DNTB. 
Baer and his coworkers (10 ,18] suggested that since DNTB was 
less reactive with proteins such as bovine serum albumin, it 
was lost from the sensitizing depot and entered the blood and 
induced tolerance in a manner similar to that described by 
Macher and Chase (19,20] . Sommer et al [11] subsequently 
demonstrated that in guinea pigs, DNTB induced a state of 
partial unresponsiveness to DNFB by generating CY-sensitive 
suppressor cells and that these cells acted by competition with 
effector cells at the periphery. The unresponsiveness was not 
associated with a decrease in T-cell proliferation in the draining 
lymph nodes . 
In this study we showed that DNTB application induces 
hapten-specific suppressor T cells whose generation is pre-
vented by treatment with CY prior to attempted sensitization. 
When passively transferred into naive recipients, these cells 
suppress the recipients ' ability to become sensitized to DNFB. 
The suppression is at the induction and not at the expression 
phase of contact sensitivity. The lymphocyte proliferation stud-
ies indicate that LNC obtained 5 days after DNFB sensitization 
are far less responsive if the animals received DNTB Epi 7 
days before the DNFB. Thus DNTB application induces T 
cells which block the capacity of other T cells to become 
responsive to the cross-reacting DNFB. Interestingly, when 
DNTB is given with FCA, it is a sensitizer. 
Epicutaneously applied hapten has been previously shown to 
induce specific immunologic tolerance. Asherson et al [5] and 
Sy et al [6] have demonstrated that sub- or supraoptimal doses 
of epicutaneously applied hapten can prevent sensitization 
when the same hapten is subsequently applied at optimal 
concentration. Both groups demonstrated that suppressor T 
cells were induced, however, in contrast to those generated in 
this study, CY treatment of the mice 3 days before the initial 
hapten application abrogated the unresponsiveness, whereas 
CY treatment before DNTB application prevented the toler-
ance induced by DNTB by only 23 %. When CY was given 3 
days before attempted sensitization with DNFB the tolerance 
induced by DNTB was significantly abrogated (67%). The 
precise mechanism(s) through which CY works in this model 
is unknown. 
It is unlikely that DNTB was being lost from the sensitizing 
depot and entering the blood by virtue of its chemical and 
physical properties as it is highly insoluble in water. Binding 
studies demonstrated that DNTB was able to bind to EC as 
well as DNFB. Thus cells incubated with DNTB were even 
more densely haptenated than were those incubated with 
DNFB. It may be that tolerance induction with DNTB is 
somehow related to the chemical groups on the surface of 
epidermal cells (and in particular, Langerhans cells) with which 
the DNTB reacts. It is known, for example, that DNTB reacts 
with sulfhydryl-containing amino acids at neutral pH in vivo 
[21], whereas DNFB reacts mainly with c-amino groups [22, 
23]. However, related compounds such as DNCB also react 
mainly with sulfhydryl-containing amino ac ids and are very 
potent sensitizers when applied to the skin. 
A possible explanation as to why suppressor cells are gener-
ated following DNTB application may be related to the inter-
action between the hapten and the antigen-presenting cells 
(Langerhans cells) in skin. DNTB may bind to the Langerhans 
cells or alter the cell surface in such a way as to facilitate its 
induction of suppressor cells either in the periphery or even in 
the draining lymph nodes. It is known for example that one 
can alter Langerhans cells (with UV radiation) so t hat when 
they are haptenated (with a normally sensitizing chemical) 
they will generate suppressor T cells [24]. 
Our studies are in keeping with others [25,26] in which 
suppressor T cells may act at the induction rather than expres-
sion phase of the contact sensitivity. It may be that these 
suppressor cells ·inactivate precursor T helper cells or induce 
other feedback suppressor cells [27]. Although in most experi-
mental systems suppressor T cells are of the Lyt 1-2+3+ phen-
otype, there are numerous examples of suppressor T cells in 
delayed-type hypersensitivity bearing the Lyt 1 +2- phenotype 
[25,28, 29]. Study of the interactions of skin, and especially of 
antigen-presenting cells in skin , with chemicals such as DNTB 
and with lymphoid cells may provide further insight into how 
these suppressor cells are generated. 
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